尿液分析市场 - 全球产业规模、份额、趋势、竞争、机会和预测，按产品、按测试类型、按应用、按最终用户、按地区和竞争进行细分，2020-2030 年

2024年全球尿液分析市场规模为43.9亿美元，预计2030年将达到68.4亿美元，复合年增长率为7.67%。这一增长主要得益于糖尿病和肾臟疾病等慢性疾病的日益流行。尿液分析是一种诊断方法，透过检查尿液的物理、化学和微观特性来检测和监测一系列健康状况，包括泌尿道感染、肾臟疾病和糖尿病。作为一种非侵入性且资讯丰富的检测方法，尿液分析在早期诊断和疾病管理中的重要性日益凸显。此外，大众对泌尿和肾臟健康意识的不断提高，加上政府支持和医疗保健投入的增加，正在提高该检测的可及性，并刺激已开发市场和发展中市场的需求。

关键市场驱动因素

慢性病盛行率上升

主要市场挑战

法规遵从和品质控制

主要市场趋势

转向即时检验

目录

第 1 章：按产品概述

• 市场定义
• 市场范围
  • 覆盖的市场。
  • 考虑学习的年限
  • 主要市场区隔

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：尿液分析市场展望。

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（消耗品和仪器）
  • 按测试类型（妊娠和生育测试、生化尿液分析和沈渣尿液分析）
  • 按应用（疾病筛检及妊娠及生育）
  • 按最终使用者（诊断实验室、医院和诊所、家庭护理机构以及研究实验室和研究所）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：亚太尿液分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国 。
  • 印度 。
  • 韩国
  • 日本
  • 澳洲

第七章：欧洲尿液分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：北美尿液分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第九章：南美尿液分析市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲尿液分析市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 按产品开发

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：尿液分析市场：SWOT 分析

第 15 章：竞争格局

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories
• Cardinal Health Inc.
• Danaher Corporation
• Sysmex Corporation
• Quidel Corporation
• Becton, Dickinson & Company
• Bio-Rad Laboratories Inc.
• EKF Diagnostics Holdings plc

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Urinalysis Market was valued at USD 4.39 billion in 2024 and is projected to reach USD 6.84 billion by 2030, growing at a CAGR of 7.67%. This growth is largely driven by the increasing prevalence of chronic diseases such as diabetes and kidney disorders. Urinalysis is a diagnostic method that examines the physical, chemical, and microscopic properties of urine to detect and monitor a range of health conditions, including urinary tract infections, kidney disease, and diabetes. As a non-invasive and informative testing approach, urinalysis is gaining prominence in early diagnosis and disease management. Additionally, rising public awareness about urinary and kidney health, combined with increased government support and healthcare investment, is enhancing accessibility and fueling demand across both developed and developing markets.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global rise in chronic conditions-particularly diabetes and chronic kidney disease (CKD)-is a major factor accelerating the growth of the urinalysis market. Urinalysis is a non-invasive, affordable diagnostic tool that plays a critical role in early detection, ongoing monitoring, and treatment planning for these diseases.

According to the World Health Organization (WHO), the global population aged 60 and above is expected to reach 2.1 billion by 2050, significantly increasing the incidence of age-related illnesses such as diabetes and CKD. The International Diabetes Federation noted that 537 million adults were living with diabetes in 2021, with projections indicating this figure will rise to 643 million by 2030. Urinalysis enables detection of biomarkers like glucose, ketones, and protein in urine, making it essential for effective management and timely intervention.

Key Market Challenges

Regulatory Compliance and Quality Control

The urinalysis market faces significant regulatory and quality assurance challenges. Manufacturers must meet stringent requirements imposed by bodies such as the FDA and EMA, which involve comprehensive product testing, documentation, and adherence to Good Manufacturing Practices (GMP). These compliance processes can be time-consuming and financially demanding.

Ensuring consistency in product performance across production batches is crucial, as any variation can compromise diagnostic accuracy. This necessitates rigorous quality control mechanisms and ongoing surveillance. For example, under the FDA's Medical Device Reporting (MDR) regulation, manufacturers are required to report device-related adverse events, ensuring constant monitoring and safety validation. These high standards increase the operational burden, potentially limiting market entry for smaller players and slowing innovation due to the associated costs and complexities.

Key Market Trends

Shift Towards Point-of-Care Testing

A major trend in the urinalysis market is the transition toward point-of-care testing (POCT), driven by the need for rapid diagnostics and decentralized healthcare services. POCT enables immediate testing and results interpretation at the site of care, which enhances clinical responsiveness and patient outcomes.

Urinalysis has emerged as a key area within POCT, thanks to the development of portable, easy-to-use devices that can be deployed in clinics, emergency rooms, and even at home. These devices offer fast analysis of urine parameters like glucose, protein, and leukocytes, facilitating prompt diagnosis and treatment.

Government support has further strengthened this trend. For instance, the Centers for Medicare & Medicaid Services (CMS) in the U.S. have introduced reimbursement policies that encourage POCT use in primary care. During health crises such as the COVID-19 pandemic, regulatory bodies also accelerated the approval of POCT devices to expand diagnostic capacity, underscoring the growing role of POCT in the future of healthcare.

Key Market Players

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories
• Cardinal Health Inc.
• Danaher Corporation
• Sysmex Corporation
• Quidel Corporation
• Becton, Dickinson & Company
• Bio-Rad Laboratories Inc.
• EKF Diagnostics Holdings plc

Report Scope:

In this report, the Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urinalysis Market, By Product:

• Consumables
• Instruments

Urinalysis Market, By Test Type:

• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Urinalysis Market, By Application:

• Disease Screening
• Pregnancy & Fertility

Urinalysis Market, By End User:

• Diagnostic Laboratories
• Hospitals & Clinics
• Home Care Settings
• Research Laboratories & Institutes

Urinalysis Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Urinalysis Market.

Available Customizations:

Global Urinalysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. By Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Urinalysis Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables & Instruments)
  • 5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
  • 5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
  • 5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. Asia-Pacific Urinalysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Test Type
  • 6.2.3. By Application
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Urinalysis Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End user
  • 6.3.2. India Urinalysis Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End user
  • 6.3.3. South Korea Urinalysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End user
  • 6.3.4. Japan Urinalysis Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Test Type
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End user
  • 6.3.5. Australia Urinalysis Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Test Type
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End user

7. Europe Urinalysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Test Type
  • 7.2.3. By Application
  • 7.2.4. By End user
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Urinalysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End user
  • 7.3.2. Germany Urinalysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End user
  • 7.3.3. United Kingdom Urinalysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End user
  • 7.3.4. Italy Urinalysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End user
  • 7.3.5. Spain Urinalysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End user

8. North America Urinalysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Test Type
  • 8.2.3. By Application
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Urinalysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End user
  • 8.3.2. Mexico Urinalysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End user
  • 8.3.3. Canada Urinalysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End user

9. South America Urinalysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Test Type
  • 9.2.3. By Application
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Urinalysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End user
  • 9.3.2. Argentina Urinalysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End user
  • 9.3.3. Colombia Urinalysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End user

10. Middle East and Africa Urinalysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Test Type
  • 10.2.3. By Application
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Urinalysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End user
  • 10.3.2. Saudi Arabia Urinalysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End user
  • 10.3.3. UAE Urinalysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. By Product Developments

13. Porters Five Forces Analysis

• 1.1. Competition in the Industry
• 1.2. Potential of New Entrants
• 1.3. Power of Suppliers
• 1.4. Power of Customers
• 1.5. Threat of Substitute Products/Services

14. Urinalysis Market: SWOT Analysis

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. By Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Siemens Healthineers AG
• 15.3. Abbott Laboratories
• 15.4. Cardinal Health Inc.
• 15.5. Danaher Corporation
• 15.6. Sysmex Corporation
• 15.7. Quidel Corporation
• 15.8. Becton, Dickinson & Company
• 15.9. Bio-Rad Laboratories Inc.
• 15.10. EKF Diagnostics Holdings plc

16. Strategic Recommendations

17. About Us & Disclaimer